The stability of remifentanil hydrochloride and propofol mixtures in polypropylene syringes and polyvinylchloride bags at 22°-24°C

Anesthesia and Analgesia

Volumn 90, Issue 6, 2000, Pages 1450-1451

  Stewart, James T ^a   Warren, Flynn W ^a   Maddox, Frances C ^a   Viswanathan, Karthick ^a   Fox, Janet L ^b  

^a UNIVERSITY OF GEORGIA   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLASTIC; PROPOFOL; REMIFENTANIL;

ARTICLE; DRUG MIXTURE; DRUG STABILITY; PRIORITY JOURNAL; SYRINGE; THERMOSTABILITY;

EID: 0034035013     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-200006000-00037     Document Type: Article

References (4)

1. ® (remifentanil hydrochloride) for injection [package insert]. Research Triangle Park: Glaxo-Wellcome Inc., 1996.
2. ® (propofol) injectable emulsion monograph, Zeneca Pharmaceuticals, Wilmington, DE 19897. In: Physicians desk reference. 52nd ed. Montvale, NJ: Medical Economics Co., 1998: 3157-62.
3. Viswanathan K, Stewart JT. HPLC determinations of propofol and remifentanil mixtures. J Liq Chrom Relat Technol 1999;22: 923-31.
4. Trissel LA. Avoiding common flaws in stability and compatibility studies of injectable drugs. Am J Hosp Pharm 1983;40: 1159-60.